Theriva Biologics, Inc. (TOVX)
↓ Download CSV- Sector Manufacturing
- Incorporated NV
- Fiscal year ends Dec 31
Key ratios (FY2025)
-154.3%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -$24.05M | -$26.35M | -$21.43M | -$21.58M | -$14.27M | -$10.16M | -$15.66M | -$17.57M | -$26.25M | -$39.25M |
| Net Income | -$23.74M | -$25.65M | -$18.35M | -$19.68M | -$14.27M | -$10.12M | -$15.38M | -$13.42M | -$15.49M | -$27.80M |
| EPS (Diluted) | $-2.08 | $-19.03 | $-28.48 | $-1.31 | $-1.90 | $-0.66 | — | — | — | — |
| Total Assets | $38.24M | $35.35M | $55.22M | $71.86M | $70.36M | $8.41M | $17.23M | $30.14M | $18.84M | $22.50M |
| Total Liabilities | $22.86M | $16.29M | $15.52M | $17.30M | $4.96M | $3.15M | $5.75M | $3.69M | $10.20M | $20.25M |
| Shareholders' Equity | $15.38M | $19.07M | $36.96M | $51.83M | $65.41M | -$7.54M | -$1.06M | $14.16M | -$3.41M | $2.26M |
| Cash & Equivalents | $13.06M | $11.61M | $23.18M | $41.79M | $67.33M | $6.23M | $15.04M | $28.92M | $17.12M | $19.05M |
| Operating Cash Flow | -$16.67M | -$16.94M | -$19.00M | -$19.08M | -$12.89M | -$12.17M | -$13.87M | -$17.28M | -$20.20M | -$27.90M |
| Capital Expenditures | $35.0K | $1.0K | $202.0K | $116.0K | $14.0K | $9.0K | $0 | $7.0K | $212.0K | $569.0K |
| Shares Outstanding | 35.69M | 2.78M | 686.2K | 15.12M | 13.20M | 29.25M | 16.81M | 15.48M | 3.67M | 117.17M |